PAMU
IONS icon

Pictet Asset Management (UK)’s Ionis Pharmaceuticals IONS Stock Holding History

Pictet Asset Management (UK)’s Portfolio IONS Stock Details IONS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		$5.36M Buy
134,324
+85,324
+174% +$3.34M 0.01% 833
2021
Q1 		$2.2M Sell
49,000
-7,000
-13% -$390K ﹤0.01% 971
2020
Q4 		$3.17M Buy
56,000
+7,100
+15% +$354K ﹤0.01% 903
2020
Q3 		$2.32M Sell
48,900
-2,000
-4% -$111K ﹤0.01% 876
2020
Q2 		$3M Buy
50,900
+1,200
+2% +$66.8K 0.01% 801
2020
Q1 		$2.35M Buy
49,700
+3,500
+8% +$195K 0.01% 824
2019
Q4 		$2.79M Sell
46,200
-111,800
-71% -$6.66M ﹤0.01% 876
2019
Q3 		$9.47M Buy
158,000
+7,500
+5% +$489K 0.02% 543
2019
Q2 		$9.67M Buy
150,500
+67,600
+82% +$4.78M 0.02% 533
2019
Q1 		$6.73M Buy
82,900
+28,300
+52% +$1.83M 0.01% 635
2018
Q4 		$2.95K Buy
54,600
+15,700
+40% +$801K 0.01% 768
2018
Q3 		$2.01M Hold
38,900
– – ﹤0.01% 893
2018
Q2 		$1.62M Buy
+38,900
New +$1.72M ﹤0.01% 817
2016
Q3 		– Sell
-75,628
Closed -$1.72M – 839
2016
Q2 		$1.72M Buy
75,628
+1,828
+2% +$59K 0.01% 755
2016
Q1 		$2.55M Buy
73,800
+32,600
+79% +$1.32M 0.01% 656
2015
Q4 		$2.55M Sell
41,200
-4,400
-10% -$237K 0.01% 689
2015
Q3 		$1.84M Sell
45,600
-116,200
-72% -$6.01M 0.01% 733
2015
Q2 		$8.89M Buy
161,800
+100,906
+166% +$6.42M 0.04% 447
2015
Q1 		$3.45M Buy
60,894
+45,315
+291% +$3.07M 0.01% 662
2014
Q4 		$962K Buy
+15,579
New +$769K ﹤0.01% 805
2014
Q2 		– Sell
-52,700
Closed -$2.28M – 880
2014
Q1 		$2.28M Sell
52,700
-31,400
-37% -$1.52M 0.01% 723
2013
Q4 		$3.35M Buy
84,100
+63,400
+306% +$2.26M 0.02% 623
2013
Q3 		$777K Buy
+20,700
New +$618K ﹤0.01% 788

Other funds holding IONS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

Pictet Asset Management (UK)'s IONS Position: Q2 2021 in Review

Pictet Asset Management (UK) increased its Ionis Pharmaceuticals (IONS) stake by 174% in Q2 2021, buying an estimated $3.34M and bringing the position to 134,324 shares worth $5.36M. The position accounts for 0.01% of the portfolio, ranked #833.

Pictet Asset Management (UK) first reported a position in IONS in Q3 2013 and has held it in 23 quarters since. The position peaked at $9.67M in Q2 2019. 337 funds tracked by Wall St. Rank hold IONS as of Q2 2021.

  • Pictet Asset Management (UK) held 134,324 shares of Ionis Pharmaceuticals worth $5.36M as of Q2 2021.
  • Pictet Asset Management (UK) bought 85,324 Ionis Pharmaceuticals shares in Q2 2021, an estimated $3.34M.
  • Ionis Pharmaceuticals made up 0.01% of Pictet Asset Management (UK)'s portfolio in Q2 2021, its #833 holding.
  • Pictet Asset Management (UK) first reported a position in Ionis Pharmaceuticals in Q3 2013 and has held it in 23 quarters since.
  • Pictet Asset Management (UK)'s Ionis Pharmaceuticals position peaked at $9.67M in Q2 2019.
  • 337 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q2 2021.

Based on Pictet Asset Management (UK)'s 13F filing for Q2 2021, filed 16 Aug 2021.